FIELD: medicine, pharmacy.
SUBSTANCE: invention relates to sustained-release medicinal formulation composition comprising venlafaxin hydrochloride as an active component. In this formulation venlafaxin hydrochloride in common with a binding agent is applied on inert core as lozenge form (nonpareil) followed applying with a cover-insulating polymeric layer for providing stability and additional cover with external polymeric layer providing the sustained-release of venlafaxin hydrochloride.
EFFECT: improved and valuable properties of composition.
18 cl, 1 tbl, 4 ex
Authors
Dates
2008-01-20—Published
2002-11-07—Filed